Novartis reportedly decides to pass on Cytokinetics
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hiya! Did you catch
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hiya! Did you catch
SAN FRANCISCO — Hospital leaders spent a good chunk of their stage time at the J.P. Morgan Healthcare Conference talking up their billions in cash
In the latest bid to lower the cost of medicines, a new bill was introduced in Congress that would make it harder for pharmaceutical companies
Medicare Advantage is arguably the most controversial health care program right now — a sentiment that was bolstered Friday by striking new data about overpayments
The Food and Drug Administration’s unprecedented approval of Florida’s plan to import drugs from Canada was made possible only after Alex Azar, as the Trump
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The U.K. medtech regulator shared a
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Interference between magnets in certain
In this new episode of omg OMx, Kate Stumpo speaks to Bruker’s Mike Greig about the incredible potential of mass spectrometry in pharma.
A new study explores the use of large language models (LLMs) to obtain such vital data from EHRs to improve research outcomes and offer better